Orexo develops improved specialty pharmaceuticals and treatments for new areas of use – at a lower cost, in a shorter period of time and at a lower risk – by combining known substances with patented proprietary technologies.
Launched products
Zubsolv® is a product for the maintenance treatment of opioid dependence. On July 3, 2013, the product was approved by the U.S. Food and Drug Administration, FDA and on September...
Orexo develops improved specialty pharmaceuticals and treatments for new areas of use – at a lower cost, in a shorter period of time and at a lower risk – by combining known substances with patented proprietary technologies.
Launched products
Zubsolv® is a product for the maintenance treatment of opioid dependence. On July 3, 2013, the product was approved by the U.S. Food and Drug Administration, FDA and on September 16, 2013, the product was launched on the US market.
Sponsored Ad
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.